In this episode we discuss how the Care Oncology Clinic supports cancer patients with integrating repurposed drugs into their treatment regime.
The clinic aims to complement standard treatments with repurposed drugs under the guidance of expert clinicians in order to deliver a safe, evidence based approach. Data is collected in order to improve outcomes for patients with various forms of cancer.
We discuss the drug selection process, how safety and efficacy is monitored, what are the findings so far and future directions of the clinic.
Resources mentioned in discussion:
The Frontiers paper from 2019 which takes in research methods and strategy, and discusses some of the challenges associated with generating good quality real world evidence. It also present preliminary outcomes data in our cohort of 95 GBM patients:
https://www.frontiersin.org/articles/10.3389/fphar.2019.00681/full
The best place for patients to find white papers aggregating a sample of relevant research literature on the COC Protocol meds in the context of different types of disease is on the US sister company website under the tab “COC – Select Cancer Types”. For example, here is the link to one on Ovarian cancer: https://careoncology.com/the-coc-protocol-in-ovarian-cancer/